Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBEX Innovations is a UK private healthcare technology company focused on bone health and medical X-ray imaging software. Its lead commercial product, IBEX BH, uses routine digital radiographs to generate DXA-like bone health outputs, including areal bone mineral density, T-score, and fracture-risk-related screening information, with no change to imaging hardware or exam protocol. The company positions this as an opportunistic osteoporosis case-finding tool designed to improve early diagnosis and support downstream care. IBEX also markets its broader IBEX Trueview platform for scatter correction, image enhancement, and reconstruction in X-ray imaging, and has worked with imaging OEMs including Nordson and Agfa Radiology. The business appears to be active, privately held, and focused primarily on commercial deployment of software-enabled diagnostic imaging products rather than a therapeutics pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IBEX Innovations.